Early research (Phase 1)Not Yet RecruitingNCT05611424What this trial is testingGene Therapy for Wet AMDWho this might be right forNeovascular Age-related Macular Degeneration Frontera Therapeutics 18
Not applicableStudy completedNCT02194803What this trial is testingObservation of Treatment Patterns With Lucentis in Approved IndicationsWho this might be right forNeovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV Novartis Pharmaceuticals 5,778
Large-scale testing (Phase 3)UnknownNCT00533689What this trial is testingStudy of the Long-Term Effect of Frequent Anti-VEGF Dosing on Retinal Function in Patients With Neovascular AMDWho this might be right forElectrophysiology Tel-Aviv Sourasky Medical Center 2,008
Early research (Phase 1)Study completedNCT04370379What this trial is testingTrial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD PatientsWho this might be right forNeovascular Age-related Macular Degeneration Innovent Biologics (Suzhou) Co. Ltd. 18
Post-approval studies (Phase 4)Looking for participantsNCT07367282What this trial is testingEvaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular DegenerationWho this might be right forMacular Degeneration Junyeop Lee 64
Early research (Phase 1)Study completedNCT02022540What this trial is testingPhase 1 Study of Topical Ocular PAN-90806 for Neovascular AMDWho this might be right forAge-Related Macular Degeneration (AMD) PanOptica, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT02462889What this trial is testingIAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMDWho this might be right forAge-Related Macular Degeneration Jeffrey S Heier 128
Large-scale testing (Phase 3)Study completedNCT00509795What this trial is testingVascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)Who this might be right forMacular Degeneration Regeneron Pharmaceuticals 1,217
Testing effectiveness (Phase 2)Looking for participantsNCT05986864What this trial is testingPhase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular Degeneration Skyline Therapeutics (US) Inc. 68
Post-approval studies (Phase 4)Study completedNCT02161575What this trial is testingSafety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMDWho this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 103
Not applicableEnded earlyNCT05038371What this trial is testingConnective Tissue Growth Factor in Patients With Neovascular Age Related Macular DegenerationWho this might be right forWet Macular Degeneration Johns Hopkins University 20
Large-scale testing (Phase 3)Study completedNCT05155293What this trial is testingClinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)Who this might be right forNeovascular (Wet) AMD Alvotech Swiss AG 413
Not applicableUnknownNCT05562336What this trial is testingOptical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).Who this might be right forChoroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia Sohag University 2
Not applicableActive Not RecruitingNCT06439576What this trial is testingReal World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)Who this might be right forDiabetic Macular EdemaNeovascular Age-related Macular DegenerationRetinal Vein Occlusion Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)Study completedNCT02121353What this trial is testingSafety Study of PF582 Versus Lucentis in Patients With Age Related Macular DegenerationWho this might be right forAge Related Macular Degeneration (AMD) Pfenex, Inc 25
Testing effectiveness (Phase 2)Looking for participantsNCT07776522What this trial is testingPhase II Study of Subretinal JWK001 for Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD) Wet AMD West China Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT01940900What this trial is testingSafety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® MonotherapyWho this might be right forAge-Related Macular Degeneration Ophthotech Corporation 627
Early research (Phase 1)Study completedNCT00709527What this trial is testingARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Ophthotech Corporation 60
Early research (Phase 1)Active Not RecruitingNCT05698329What this trial is testingEffect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)Who this might be right forNeovascular Age-related Macular DegenerationDiabetic Macular EdemaMacular Edema AiViva BioPharma, Inc. 19
Not applicableActive Not RecruitingNCT04645212What this trial is testingLong-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]Who this might be right forWet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration Adverum Biotechnologies, Inc. 23